Cyanocobalamin - QOL Medical

Drug Profile

Cyanocobalamin - QOL Medical

Alternative Names: Intranasal cyanocobalamin; Nascobal; Vitamin B12 - QOL Medical

Latest Information Update: 27 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator QOL Medical
  • Class Corrinoids; Vitamin B12 analogues
  • Mechanism of Action Methylmalonyl CoA mutase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Anaemia; Vitamin B deficiency

Most Recent Events

  • 10 Jun 2014 Registered for Anaemia (new dosage form; single-use device) in USA (Intranasal)
  • 10 Jun 2014 Registered for Vitamin B deficiency (new dosage form; single-use device) in USA (Intranasal)
  • 26 Oct 2010 Cyanocobalamin nasal spray licensed to Swedish Orphan Biovitrum in Europe
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top